Boston Scientific Corp (BSX) - Product Pipeline Analysis, 2024 Update
Summary
Boston Scientific Corp (Boston Scientific) is a medical technology company that develops, manufactures and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology, and vascular surgery. Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia and Puerto Rico. It sells products directly and also through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Boston Scientific Corp
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Boston Scientific Corp Company Overview
Boston Scientific Corp Company Snapshot
Boston Scientific Corp Pipeline Products and Ongoing Clinical Trials Overview
Boston Scientific Corp – Pipeline Analysis Overview
Business Description
Boston Scientific Corp - Key Facts
Boston Scientific Corp - Major Products and Services
Boston Scientific Corp Pipeline Products by Development Stage
Boston Scientific Corp Ongoing Clinical Trials by Trial Status
Table 24: ACOART Sirolimus Coated Balloon Catheter - A Prospective, Multicenter, Random Controlled Clinical Trail to Evaluate the Effectiveness and Safety of Sirolimus Coated Balloon Versus a Paclitaxel Coated Balloon in the Treatment of Coronary Bifurcation Lesion
Table 25: ACOART Sirolimus Coated Balloon Catheter - A Prospective, Multicenter, Randomized Controlled Trial Comparing the Efficacy and Safety Between Sirolimus Coated Balloon Catheter and Paclitaxel Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis
Table 26: AcoArt-Litos Drug-Eluting Balloon - Product Status
Table 28: AcoArt-Litos Drug-Eluting Balloon - A Post Market Clinical Study to Evaluate the Safety and Efficacy of the Acotec Drug-coated Balloon in the Treatment of the Below-the-knee Artery
Table 29: AcoArt-Litos Drug-Eluting Balloon - All Comers Post Market Clinical Follow-up to Continue the Surveillance of the Acotec Drug Coated PTA Catheter Orchid, Tulip and Litos in Lower Limb Treatment
Table 30: AcoArt-Litos Drug-Eluting Balloon - Comparison of Sirolimus Vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia
Table 31: AcoArt-Tulip - Product Status
Table 32: AcoArt-Tulip - Product Description
Table 33: AcoArt-Tulip - A Post Market Clinical Study to Evaluate the Safety and Efficacy of the Acotec Drug-coated Balloon in the Treatment of the Below-the-knee Artery
Table 34: AcoArt-Tulip - All Comers Post Market Clinical Follow-up to Continue the Surveillance of the Acotec Drug Coated PTA Catheter Orchid, Tulip and Litos in Lower Limb Treatment
Table 35: ACURATE neo2 Transfemoral TAVR System - Product Status
Table 36: ACURATE neo2 Transfemoral TAVR System - Product Description
Table 37: ACURATE neo2 Transfemoral TAVR System - ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects Indicated for TAVR
Table 38: ACURATE neo2 Transfemoral TAVR System - ACURATE neo2 Post Market Clinical Follow up Study
Table 39: ACURATE neo2 Transfemoral TAVR System - Project to Look for Early Discharge in Patients Undergoing TAVI With ACURATE - An International Multi-center Early Discharge TAVI Program
Table 40: ACURATE neo2 Transfemoral TAVR System - Prospective Evaluation Complementing Investigation with Acurate Neo Device
Table 41: ACURATE neo2 Transfemoral TAVR System - Prospective, Randomized, Cost-utility Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Brazil
Table 42: ACURATE neo2 Transfemoral TAVR System - PROVE ACURATE neo2 - Post Market Safety and Performance Surveillance in Aortic Stenosis
Table 43: ACURATE neo2 Transfemoral TAVR System - Randomized Study Comparing Both Latest Generation Self-expanding Valves and Local Anesthesia Vs. Conscious Sedation in Transcatheter Aortic Valve Implantation
Table 44: ACURATE neo2 Transfemoral TAVR System - The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis
Table 45: ACURATE Prime - Product Status
Table 46: ACURATE Prime - Product Description
Table 47: ACURATE Prime XL Transfemoral Aortic Valve System - Product Status
Table 48: ACURATE Prime XL Transfemoral Aortic Valve System - Product Description
Table 49: ACURATE TA LP Transapical Delivery System - Product Status
Table 50: ACURATE TA LP Transapical Delivery System - Product Description
Table 51: ACURATE TAo - Product Status
Table 52: ACURATE TAo - Product Description
Table 53: AECG System (Ambulatory External Electrocardiography) - Product Status
Table 54: AECG System (Ambulatory External Electrocardiography) - Product Description
Table 55: AECG System (Ambulatory External Electrocardiography) - Tulane iPredict, Prevent (TiPP) Study
Table 56: Agent Paclitaxel Coated-PTCA Balloon Catheter - Product Status
Table 58: Agent Paclitaxel Coated-PTCA Balloon Catheter - AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects with In-Stent Restenosis (ISR)
Table 59: Agent Paclitaxel Coated-PTCA Balloon Catheter - Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
Table 60: Agent Paclitaxel Coated-PTCA Balloon Catheter - Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease